BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic Hepatitis B
1
Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey
12/25/2025 9:13:55 AM | Browse: 13 | Download: 46
2
Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B
11/28/2025 3:10:38 AM | Browse: 26 | Download: 112
3
Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B
11/4/2025 2:41:47 AM | Browse: 37 | Download: 118
4
Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice
10/27/2025 10:57:50 AM | Browse: 129 | Download: 144
5
Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
10/24/2025 7:36:34 AM | Browse: 150 | Download: 132
6
Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B
10/24/2025 7:36:26 AM | Browse: 126 | Download: 30
7
Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies
9/26/2025 8:18:47 AM | Browse: 330 | Download: 201
8
Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report
9/25/2025 11:24:05 AM | Browse: 95 | Download: 161
9
Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years
9/25/2025 11:24:00 AM | Browse: 108 | Download: 182
10
Chronic hepatitis B: Is it time for expanded antiviral treatment?
9/25/2025 9:22:03 AM | Browse: 97 | Download: 134
11
Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics
7/25/2025 12:09:41 PM | Browse: 76 | Download: 276
12
Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis
7/15/2025 8:26:32 AM | Browse: 71 | Download: 419
13
Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B
7/4/2025 9:23:52 AM | Browse: 102 | Download: 414
14
Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B
5/27/2025 7:04:48 AM | Browse: 73 | Download: 481
15
Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease
5/27/2025 7:04:47 AM | Browse: 86 | Download: 508
16
Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients
3/13/2025 10:11:05 AM | Browse: 84 | Download: 450
17
Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment
2/26/2025 4:21:35 AM | Browse: 59 | Download: 328
18
CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment
12/20/2024 3:53:46 AM | Browse: 35 | Download: 75
19
Current status of drug therapy for chronic hepatitis B
12/18/2024 7:36:02 AM | Browse: 90 | Download: 500
20
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 143 | Download: 625
21
Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
11/29/2024 2:50:18 PM | Browse: 148 | Download: 814
22
Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens
11/12/2024 6:08:07 AM | Browse: 112 | Download: 823
23
Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action
11/6/2024 9:50:59 AM | Browse: 181 | Download: 696
24
Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway
10/31/2024 10:42:49 AM | Browse: 136 | Download: 539
25
Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
10/21/2024 7:03:25 AM | Browse: 143 | Download: 530
26
Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered
7/26/2024 10:33:30 AM | Browse: 129 | Download: 687
27
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
7/26/2024 10:33:30 AM | Browse: 207 | Download: 872
28
Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients
7/9/2024 2:00:35 PM | Browse: 102 | Download: 514
29
Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors
6/25/2024 10:41:21 AM | Browse: 197 | Download: 585
30
Hepatitis B cure: Current situation and prospects
6/20/2024 3:42:22 AM | Browse: 165 | Download: 663
31
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
6/20/2024 3:42:22 AM | Browse: 147 | Download: 924
32
Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy
3/27/2024 1:28:19 PM | Browse: 193 | Download: 982
33
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study
3/11/2024 2:44:49 PM | Browse: 278 | Download: 1144
34
Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis
3/6/2024 6:10:52 AM | Browse: 237 | Download: 928
35
Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study
2/4/2024 10:57:42 AM | Browse: 323 | Download: 1276
36
Antiviral treatment standards for hepatitis B: An urgent need for expansion
1/26/2024 7:56:29 AM | Browse: 353 | Download: 1015
37
Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
12/6/2023 8:08:49 AM | Browse: 310 | Download: 1135
38
Tenofovir amibufenamide vs tenofovir alafenamide for treating chronic hepatitis B: A real-world study
11/27/2023 5:08:21 PM | Browse: 264 | Download: 1033
39
Effects of different intervention methods on psychological flexibility, negative emotions and sleep quality in chronic hepatitis B
10/12/2023 4:44:25 AM | Browse: 244 | Download: 1045
40
Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients
9/14/2023 2:58:54 PM | Browse: 334 | Download: 1311
41
Hepatitis B virus infection in patients with Wilson disease: A large retrospective study
8/25/2023 7:09:14 AM | Browse: 254 | Download: 1198
42
Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
6/28/2023 10:03:21 AM | Browse: 314 | Download: 937
43
Sarcopenia in chronic viral hepatitis: From concept to clinical relevance
5/24/2023 9:31:05 AM | Browse: 338 | Download: 987
44
Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication
4/24/2023 11:14:10 AM | Browse: 311 | Download: 1332
45
Clinicopathological features of 11 cases of chronic hepatitis B infection complicated with primary biliary cholangitis
4/20/2023 7:26:29 AM | Browse: 315 | Download: 1480
46
Locked nucleic acid real-time polymerase chain reaction method identifying two polymorphisms of hepatitis B virus genotype C2 infections, rt269L and rt269I
3/17/2023 6:20:53 AM | Browse: 369 | Download: 1574
47
Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
2/14/2023 7:03:16 AM | Browse: 311 | Download: 1408
48
Correlation between COVID-19 and hepatitis B: A systematic review
12/8/2022 9:04:30 AM | Browse: 570 | Download: 1806
49
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C
9/27/2022 1:00:17 PM | Browse: 528 | Download: 1601
50
Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B
8/26/2022 9:51:35 AM | Browse: 447 | Download: 1676